A doctor holds the Pfizer BioNTech vaccine and syringe to protect against the coronavirus disease. (Photo: lakshmiprasada S/Shutterstock)

For millions of Americans, the emergency authorization of two COVID-19 vaccines by the federal government was a bright spark of hope in what has been an otherwise bleak pandemic winter. Indeed, according to preliminary modeling from Verisk's Life Risk Navigator platform, the United States could potentially achieve the long-sought herd immunity by the fall of 2021 thanks, in part, to these very vaccines.

Recommended For You

Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader

Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
  • Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
NOT FOR REPRINT

© Touchpoint Markets, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more inforrmation visit Asset & Logo Licensing.